[{"NetIncomeLoss_1_Q1_USD":-24275000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":49000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-2387000.0,"PaymentsToAcquireInvestments_1_Q1_USD":47742000.0,"AssetsCurrent_0_Q1_USD":310768000.0,"OperatingLeaseExpense_1_Q1_USD":800000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":5251736.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":394000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-38000.0,"CommonStockSharesIssued_0_Q1_shares":39119315.0,"CommitmentsAndContingencies_0_Q1_USD":null,"Assets_0_Q1_USD":396660000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":9846362.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"LitigationSettlementExpense_1_Q1_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-1335000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_0_Q1_USD":170000.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"OperatingIncomeLoss_1_Q1_USD":-24522000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_1_Q1_USD":2174000.0,"ShareBasedCompensation_1_Q1_USD":2700000.0,"IncomeTaxesReceivable_0_Q1_USD":4000000.0,"InterestAndOtherIncome_1_Q1_USD":318000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":6530000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":16990000.0,"ShortTermInvestments_0_Q1_USD":176692000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":23003000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":71000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q1_USD":3438000.0,"CommonStockValue_0_Q1_USD":39000.0,"Revenues_1_Q1_USD":5011000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":1359000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q1_USD":2342000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":38777258.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-24313000.0,"OtherAssetsNoncurrent_0_Q1_USD":1571000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":126381000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_1_Q1_USD":46198000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":398018000.0,"Liabilities_0_Q1_USD":126527000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-38000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.0,"DepreciationAndAmortization_1_Q1_USD":643000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":899000.0,"IncreaseDecreaseInIncomeTaxesReceivable_1_Q1_USD":135000.0,"IncomeTaxReceivable_0_Q1_USD":3981000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":32751000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":13826000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q1_USD":3541000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-24204000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2700000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":8053000.0,"LiabilitiesCurrent_0_Q1_USD":47972000.0,"AccountsPayableCurrent_0_Q1_USD":4388000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":126381000.0,"IncreaseDecreaseInContractWithCustomerAsset_1_Q1_USD":-7500000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q1_USD":3365000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":3714000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_1_Q1_USD":200000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q1_security":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_1_Q1_USD":0.0,"SecurityDeposit_0_Q1_USD":91000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":126551000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":1043000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":668000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":6960000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":317000.0,"RestrictedCashNoncurrent_0_Q1_USD":170000.0,"CommonStockSharesOutstanding_0_Q1_shares":39119315.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":7025000.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":396660000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":7266000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":49700000.0,"IncomeTaxExaminationInterestAccrued_0_Q1_USD":100000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":20786000.0,"OperatingExpenses_1_Q1_USD":29533000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.63,"ProfitLoss_1_Q1_USD":-24275000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":832000.0,"OtherLiabilitiesCurrent_0_Q1_USD":696000.0,"StockholdersEquity_0_Q1_USD":270133000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":77723000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":843000.0,"LongTermInvestments_0_Q1_USD":77191000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-222000.0,"TaxesPayableCurrent_0_Q1_USD":325000.0,"OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0_Q1_USD":1493000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-127973000.0,"CurrentIncomeTaxExpenseBenefit_1_Q1_USD":71000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1141000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q1_USD":14179000.0,"Ticker":"NRIX","CIK":"1549595","name":"NURIX THERAPEUTICS, INC.","OfficialName":"Nurix Therapeutics Inc. Common stock","form":"10-Q","period":"20210228","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"593342561.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210413"}]